|
|
Other links at Articles > Business of Medicine |
| 1. |
Cephalon Wins U.S. Approval of Treanda for CLL
|
|
|
Cephalon Inc has won approval from the U.S. Food and Drug Administration to sell Treanda (bendamustine) to treat patients with chronic lymphocytic leukemia, or CLL, the company said on Thursday. Reuters Health Information
|
| 5. |
Hospira Wins European Approval for Retacrit
|
|
|
Hospira Inc said on Wednesday it won European approval to sell Retacrit, a generic version of erythropoietin, as a treatment for anemia associated with chronic renal failure and chemotherapy. Reuters Health Information
|
|
|